HIV/AIDS
Studies from Emory University, Medical Department have provided new data on HIV/AIDS
Published in Vaccine Weekly, January 30th, 2008
"HIV pseudovirion or virus-like particle vaccines represent a promising approach for eliciting Immoral and cellular immune responses. Pseudovirions present the envelope glycoprotein complex in its authentic trimeric form, and thus have the potential to generate neutralizing antibodies against relevant virion-associated epitopes that may be lacking in protein subunit vaccines," scientists in the United States report.
"The development of pseudovirion particles as a viable vaccine approach for progression to clinical testing has been limited by a number of factors, including shedding of particle-associated gp120, practical limitations to large-scale production and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-01-30)
More Articles from Vaccine Weekly
- HIV/AIDS
Keeping young South Africans in school: A 'social vaccine' against AIDS - HIV/AIDS
Uncovering the Achilles' heel of the HIV-1 envelope - HIV/AIDS
Study findings from Emory University, Emory Vaccine Center provide new insights into HIV/AIDS - Human Papillomavirus
New findings from Korea University describe advances in human papillomavirus - Immunization
Reports by V.E.J.C. Schijns and co-researchers describe recent advances in immunization - The Children's Hospital of Philadelphia
Medicaid Reimbursement for Car Seats Is Cost-Effective Health Policy - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
